Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
HBIO
$6.66
-0.22%
HBIO · Harvard Bioscience Inc
$6.66
-0.02 (-0.22%)
At close · Aug 14
Market Cap
$30.30M
Shares
4.55M
All earnings calls
Earnings call · FY2026 Q2
Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET
Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET
Forward guidance
5 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$22.73M
+11.1% YoY
Diluted EPS
-$0.64
Gross margin
55.6%
-0.8 pp YoY
Net income
-$2.91M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 11, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Revenue
Initiated
third quarter 2026
|
$21M – $22.6M | — | |
|
Adjusted gross margin
Initiated
third quarter 2026
|
56% – 58% | Non-GAAP | |
|
Adjusted EBITDA
Initiated
third quarter 2026
|
$1.5M – $2.5M | Non-GAAP | |
|
Adjusted gross margin
Initiated
full year 2026
|
57% – 59% | Non-GAAP | |
|
Adjusted EBITDA growth
Initiated
full year 2026
|
6% – 10% | Non-GAAP |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 11, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 11, 2026 · complete as-filed document